UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities

Nature reviews. Rheumatology, 2012-01, Vol.8 (1), p.42-54

2012

Volltextzugriff (PDF)

Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis)

The Journal of pathology, 2013-01, Vol.229 (2), p.286-297

2013

Volltextzugriff (PDF)

Tenascin-C drives persistence of organ fibrosis

Nature communications, 2016-06, Vol.7 (1), p.11703-11703, Article 11703

2016

Volltextzugriff (PDF)

Fibrosis in systemic sclerosis: Emerging concepts and implications for targeted therapy

Autoimmunity reviews, 2011-03, Vol.10 (5), p.267-275

2011

Volltextzugriff (PDF)

Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis

Frontiers in immunology, 2018-10, Vol.9, p.2434-2434

2018

Volltextzugriff (PDF)

The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib

Journal of scleroderma and related disorders, 2020-02, Vol.5 (1), p.40-50

2020

Volltextzugriff (PDF)

A synthetic TLR3 ligand mitigates profibrotic fibroblast responses by inducing autocrine IFN signaling

The Journal of immunology (1950), 2013-09, Vol.191 (6), p.2956-2966

2013

Volltextzugriff (PDF)

Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs

Nature communications, 2022-10, Vol.13 (1), p.6358-6358, Article 6358

2022

Volltextzugriff (PDF)

Early growth response transcription factors: Key mediators of fibrosis and novel targets for anti-fibrotic therapy

Matrix biology, 2011-05, Vol.30 (4), p.235-242

2011

Volltextzugriff (PDF)

Fibronectin EDA forms the chronic fibrotic scar after contusive spinal cord injury

Neurobiology of disease, 2018-08, Vol.116, p.60-68

2018

Volltextzugriff (PDF)

Status of Vitamin B12 Deficiency among Lactating Mothers at Six Weeks Postpartum at a Tertiary Care Hospital, West Bengal, India

NATIONAL JOURNAL OF LABORATORY MEDICINE, 2024

2024

Volltextzugriff (PDF)

Perception of Students and Faculties towards Implementation of Concept Mapping in Pharmacology: A Cross-sectional Interventional Study

Journal of clinical and diagnostic research, 2021-04, Vol.15 (4), p.FC08-FC13

2021

Volltextzugriff (PDF)

Author Correction: Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs

Nature communications, 2023-01, Vol.14 (1), p.523-523, Article 523

2023

Volltextzugriff (PDF)

The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy

Arthritis research & therapy, 2012-10, Vol.14 (5), p.R229-R229

2012

Volltextzugriff (PDF)

Toll-Like Receptor-4 Signaling Drives Persistent Fibroblast Activation and Prevents Fibrosis Resolution in Scleroderma

Advances in wound care (New Rochelle, N.Y.), 2017-10, Vol.6 (10), p.356-369

2017

Volltextzugriff (PDF)

Role of RP105 and A20 in negative regulation of toll-like receptor activity in fibrosis: potential targets for therapeutic intervention

AIMS allergy and immunology, 2021-01, Vol.5 (2), p.102-126

2021

Volltextzugriff (PDF)

Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy

Immunology letters, 2018-03, Vol.195, p.9-17

2018

Volltextzugriff (PDF)

Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures

Arthritis research & therapy, 2015-07, Vol.17 (1), p.194, Article 194

2015

Volltextzugriff (PDF)

Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis

iScience, 2021-01, Vol.24 (1), p.101902-101902, Article 101902

2021

Volltextzugriff (PDF)

Essential Roles for Early Growth Response Transcription Factor Egr-1 in Tissue Fibrosis and Wound Healing

The American journal of pathology, 2009-09, Vol.175 (3), p.1041-1055

2009

Volltextzugriff (PDF)

Deficiency of inhibitory TLR4 homolog RP105 exacerbates fibrosis

JCI insight, 2022-11, Vol.7 (21)

2022

Volltextzugriff (PDF)

A Randomized Controlled Trial to Compare the Efficacy, Safety and Tolerability of Asenapine versus Olanzapine in Management of Schizophrenia

Clinical Psychopharmacology and Neuroscience, 2020, 18(4), , pp.587-598

2020

Volltextzugriff (PDF)

Pharmacological inhibition of TAK1 prevents and induces regression of experimental organ fibrosis

JCI insight, 2023-07, Vol.8 (14)

2023

Volltextzugriff (PDF)

PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosis

JCI insight, 2022-03, Vol.7 (5)

2022

Volltextzugriff (PDF)

Egr-1 induces a profibrotic injury/repair gene program associated with systemic sclerosis

PloS one, 2011-09, Vol.6 (9), p.e23082-e23082

2011

Volltextzugriff (PDF)

1 – 25 von 211

Suche als RSS-Feed

Aktive Filter

SpracheEnglisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(182)

Publikationsform

Sprache

Japanisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities

Egr-1: new conductor for the tissue repair orchestra directs harmony (regeneration) or cacophony (fibrosis)

Tenascin-C drives persistence of organ fibrosis

Fibrosis in systemic sclerosis: Emerging concepts and implications for targeted therapy

Pharmacological Inhibition of Toll-Like Receptor-4 Signaling by TAK242 Prevents and Induces Regression of Experimental Organ Fibrosis

The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib

A synthetic TLR3 ligand mitigates profibrotic fibroblast responses by inducing autocrine IFN signaling

Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs

Early growth response transcription factors: Key mediators of fibrosis and novel targets for anti-fibrotic therapy

Fibronectin EDA forms the chronic fibrotic scar after contusive spinal cord injury

Status of Vitamin B12 Deficiency among Lactating Mothers at Six Weeks Postpartum at a Tertiary Care Hospital, West Bengal, India

Perception of Students and Faculties towards Implementation of Concept Mapping in Pharmacology: A Cross-sectional Interventional Study

Author Correction: Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs

The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy

Toll-Like Receptor-4 Signaling Drives Persistent Fibroblast Activation and Prevents Fibrosis Resolution in Scleroderma

Role of RP105 and A20 in negative regulation of toll-like receptor activity in fibrosis: potential targets for therapeutic intervention

Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy

Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures

Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis

Essential Roles for Early Growth Response Transcription Factor Egr-1 in Tissue Fibrosis and Wound Healing

Deficiency of inhibitory TLR4 homolog RP105 exacerbates fibrosis

A Randomized Controlled Trial to Compare the Efficacy, Safety and Tolerability of Asenapine versus Olanzapine in Management of Schizophrenia

Pharmacological inhibition of TAK1 prevents and induces regression of experimental organ fibrosis

PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosis

Egr-1 induces a profibrotic injury/repair gene program associated with systemic sclerosis

Aktive Filter

Suchergebnisse filtern